Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.

Clin. Orthop. Relat. Res.. 2019-07; 
Lozano CalderónSantiago A,GarbuttCassandra,KimJason,LietzChristopher E,ChenYen-Lin,BernsteinKaren,ChebibIvan,NielsenG Petur,DeshpandeVikram,RubioRenee,WangYaoyu E,QuackenbushJohn,DelaneyThomas,RaskinKevin,SchwabJoseph,CoteGregory,SpentzosDimit
Products/Services Used Details Operation
Gene Synthesis … 2,6-diaminopurine. Alternatively, one or more of the nucleic acids of the invention can be purchased from companies, such as Integrated DNA Technologies (Coralville, Iowa) and Genscript (Piscataway, NJ). The term “isolated … Get A Quote

摘要

MicroRNAs are small, noncoding RNAs that regulate the expression of posttranslational genes. The presence of some specific microRNAs has been associated with increased risk of both local recurrence and metastasis and worse survival in patients with osteosarcoma. Pathologic fractures in osteosarcoma are considered to be more the manifestation of a neoplasm with a more aggressive biological behavior than the cause itself of worse prognosis. However, this has not been proved at the biological or molecular level. Currently, there has not been a microRNA profiling study of patients who have osteosarcoma with and without pathologic fractures that has described differences in terms of microRNA profiling between ... More

关键词

XML 地图